Telesis Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Telesis Bio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0% to $27,509,000. The net income raised on -$47,724,000 and profit margin reached -173%. Total operating expenses were $63,489,000.

Profit Margin

Telesis Bio, Inc. (NASDAQ:TBIO): Profit margin
2016 0 -26.69M
2017 0 -66.44M
2018 1.42M -97.39M -6858.8%
2019 4.80M -8.30M -172.78%
2020 6.57M -18.01M -273.87%
2021 11.04M -38.95M -352.78%
2022 27.43M -48.47M -176.68%
2023 27.50M -47.72M -173.49%

TBIO Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
27.50M27.43M11.04M6.57M4.80M1.42M00
Cost of revenue
10.55M11.84M6.74M2.95M8.88M000
Gross profit
16.95M15.59M4.29M3.62M-4.08M1.42M00
Operating exp.
Research and development
17.49M23.46M14.54M8.92M1.31M58.02M47.02M15.65M
Selling and marketing
13.51M16.48M10.89M6.93M2.25M000
Total operating expenses
63.48M62.08M39.67M19.98M2.89M80.63M61.33M26.80M
Operating income
-46.53M-46.48M-35.37M-16.36M-6.97M-102.96M-78.92M-26.69M
Other income (expenses), net
-1.16M-1.96M-3.57M-1.64M-1.32M000
Income before tax
-47.7M-48.44M-38.94M-18.00M-8.30M-102.96M-78.92M-26.69M
Income tax expense
24K24K14K5K-486K-5.56M-12.48M0
Net income
-47.72M-48.47M-38.95M-18.01M-8.30M-97.39M-66.44M-26.69M
Earnings per share
Basic EPS
-1.64-1.65-1.33-0.62-0.2-2.16-2.23-0.89
Diluted EPS
-29.56-1.65-1.33-0.62-0.2-2.16-2.23-0.89
Data sourceData sourceData source